Advertisement
Person › Details
Andrew Conrad (Verily Life Sciences LLC)
Conrad, Andrew (Alphabet 201608 CEO of Verily Life Sciences)
Organisation | Verily Life Sciences LLC | |
Group | Alphabet (formerly Google) (Group) | |
Product | bioinformatics (biological software and databases) | |
Product 2 | bioelectronic medicine | |
Record changed: 2020-12-19 |
Advertisement
More documents for Andrew Conrad
- [1] Verily Life Sciences. (12/17/20). "Press Release: Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms". South San Francisco, CA....
- [2] Verily Life Sciences. (1/3/19). "Press Release: Verily Announces $1 Billion Investment Round to Fund Growth and Innovation". South San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top